Le Lézard
Classified in: Health, Business
Subject: TNM

Convey Health Solutions Acquires Gorman Health Group


FORT LAUDERDALE, Fla. and WASHINGTON, Oct. 18, 2017 /PRNewswire-iReach/ -- Convey Health Solutions ("Convey"), a leading provider of technology and services for the Medicare Advantage and Part D markets, today announced the acquisition of Gorman Health Group ("GHG"). Gorman Health Group provides market-leading technology and consulting services to help more than 150 government-sponsored health programs stay compliant, optimize revenues, and manage complex processes.

GHG's deep consulting and market expertise complement Convey's existing portfolio of compliant, cost-reducing member enrollment, service, administration, quality and wellness support solutions.  GHG's extensive market presence and real-time insight combined with Convey's technology expertise will accelerate the development and deployment of technology and services to the market. The acquisition is a critical part of Convey's growth strategy to expand its solutions and services through a combination of acquisitions and internal development of additional offerings for clients.

"The rapidly growing government-sponsored health program market is becoming increasingly complex as the rate of change accelerates; having compliant and cost effective solutions is now more essential than ever for health programs. The combined Convey/Gorman team is perfectly positioned to deploy high quality technology and service solutions. We are excited to work together to create innovative solutions that help our clients to manage their businesses", commented Stephen Farrell, CEO of Convey Health Solutions.

John Gorman, Executive Chairman and Founder of GHG said, "We recognized that to unlock the full potential of the government-sponsored healthcare market we needed best-in-class services and technology.  Together with Convey Health we have the ability to deliver both.  We are energized by the incredible opportunity we can now provide to our clients and to the healthcare market."

About Convey Health Solutions | Convey Health Solutions is a specialized healthcare technology and services company that is committed to providing clients with healthcare-specific, compliant member support solutions utilizing technology, engagement, and analytics. The company's administrative solutions for government-sponsored health plans help to optimize member interactions, ensure compliance, and support end-to-end Medicare processes. By combining its best-in-class, built-for-purpose technology platforms with dedicated and flexible business process solutions, Convey Health Solutions creates better business results and better healthcare consumer experiences on behalf of business customers and partners. The company's clients include some of the nation's leading health insurance plans and pharmacy benefit management firms. Their healthcare-focused teams help several million Americans each year to navigate the complex Medicare Advantage and Part D landscape. To learn more please visit www.ConveyHealthSolutions.com.

About Gorman Health Group | Gorman Health Group (GHG) is a leading consulting and software solutions firm specializing in government health programs, including Medicare, Medicaid, and Health Insurance Marketplace opportunities. Since 1996, GHG's unparalleled teams of subject matter experts, former health plan executives, and seasoned healthcare regulators have been providing strategic, operational, financial, and clinical services to the industry across a full spectrum of business needs. Further, the GHG software solutions have continued to place efficient and compliant operations within their client's reach. To learn more please visit www.GormanHealthGroup.com.

Media Contact: Lisha DeSantis, Convey Health Solutions, 7722936215, [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Convey Health Solutions


These press releases may also interest you

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...



News published on and distributed by: